Optimizing frontline therapy for diffuse large B cell lymphoma (DLBCL) in older adults: A glofitamab-based, response-adapted, window-style study (GLORY).

Authors: Pallawi Torka, Koshy Alexander, Kelly McConnell, Venkatraman E. Seshan, Joanna Tortora, Holly Levenstein, Olivia Kelly, Helen Jacob, Monifa Douglas, Walter Ramos Amador, Justina Kiernan, Zachary Epstein-Peterson, Lorenzo Falchi, Andrew David Zelenetz, Gilles A. Salles, Paul A. Hamlin

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps7094

Source: Full article


Abstract

TPS7094